Innovative Antimicrobial Resistant Polymers for Medical Devices


Secondary infections found in hospital environments are becoming an increasingly significant concern for patients, hospital administrators, and staff. Patient care can be negatively affected when a secondary infection caused by a variety of microorganisms commonly found in healthcare environments leads to health issues for a patient. With insurance companies no longer covering the expense for secondary infections, the cost to hospitals for the infections can lead to a negative return on their bottom line.

Evonik has introduced three new products that can resist the growth of bacteria which can be molded into medical devices that have 510k applications and have shown efficacy as tested per the JIS Z 2801 Protocol.


Larry Gabriel
Business Development Manager
Evonik Cyro LLC

Dimo Dimov
Product Development Project Manager, Molding Compounds
Evonik Cyro LLC

Click here to view webinar.